Health Care & Life Sciences » Biotechnology | Neuren Pharmaceuticals Ltd.

Neuren Pharmaceuticals Ltd. | Balance Sheet

Fiscal year is January-December. All values AUD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
24,379.00
20,824.00
16,642.00
5,051.00
15,394.00
25,697
Total Accounts Receivable
1,621.00
963.00
34.00
1,002.00
692.00
942
Other Current Assets
43.00
-
-
-
-
-
Total Current Assets
26,043.00
21,787.00
16,676.00
6,053.00
16,086.00
26,639
Net Property, Plant & Equipment
23.00
29.00
11.00
12.00
7.00
2
Total Investments and Advances
-
-
-
-
1,778.00
-
Intangible Assets
394.00
290.00
217.00
145.00
73.00
1
Total Assets
26,460.00
22,106.00
16,904.00
6,210.00
17,944.00
26,642
Accounts Payable
1,853.00
2,755.00
1,771.00
1,035.00
723.00
Other Current Liabilities
208.00
273.00
731.00
992.00
857.00
Total Current Liabilities
2,061.00
3,028.00
2,502.00
2,027.00
1,580.00
Total Liabilities
2,061.00
3,028.00
2,502.00
2,027.00
1,580.00
Common Equity (Total)
24,601.00
19,299.00
14,402.00
4,183.00
16,364.00
Total Shareholders' Equity
24,601.00
19,299.00
14,402.00
4,183.00
16,364.00
Total Equity
24,399.00
19,078.00
14,402.00
4,183.00
16,364.00
Liabilities & Shareholders' Equity
26,460.00
22,106.00
16,904.00
6,210.00
17,944.00
Accumulated Minority Interest
202.00
221.00
-
-
-

About Neuren Pharmaceuticals

View Profile
Address
697 Burke Road
Camberwell Victoria (VIC) 3124
Australia
Employees -
Website http://www.neurenpharma.com
Updated 07/08/2019
Neuren Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment and neurodegenerative disorders. The company was founded on December 17, 2001 and is headquartered in Melbourne, Australia. .